Stefan W.
- Country
- Germany
- Department
- Medizinische Klinik, Innere Medizin II
Research Overview
- Efficacy and Safety Comparison of Obinutuzumab-Venetoclax vs. Obinutuzumab-Chlorambucil in Untreated CLL with Comorbidities
- A phase 3 multicentre, randomized, prospective, open-label trial of Ibrutinib monotherapy versus fixed-duration Venetoclax plus Obinutuzumab versus fixed-duration Venetoclax plus Ibrutinib in patients with previously untreated chronic lymphocytic leukaemia (CLL) - CLL17
- Randomized European Trial of Autologous Transplantation with Rituximab, Ibrutinib, and Ara-C Induction in Generalized Mantle Cell Lymphoma
Data & Insights
Has run more than one trial at 216 of 441 partner sites.
Specializations
Lymphoma Research
Specializes in investigating therapeutic approaches for various lymphoma types, with particular emphasis on follicular lymphoma and diffuse large B-cell lymphoma (DLBCL). The investigator studies both early-stage disease and relapsed/refractory cases.
- Early-stage follicular lymphoma treatment optimization
- Relapsed/refractory lymphoma management
- Novel combination therapies for DLBCL
- Mantle cell lymphoma interventions
Focuses on integrating targeted therapies with standard treatment protocols.
Leukemia Studies
Conducts extensive research in chronic lymphocytic leukemia (CLL) treatments, with special attention to previously untreated patients and those with coexisting medical conditions.
- Treatment-naive CLL management
- High-risk CLL therapeutic approaches
- Fixed-duration treatment protocols
- Combination therapy optimization
Explores innovative treatment combinations and duration-optimized protocols.
Novel Therapeutic Approaches
Investigates cutting-edge therapeutic combinations incorporating monoclonal antibodies and targeted agents for hematologic malignancies.
- Antibody-based combination therapies
- MRD-guided treatment strategies
- Fixed-duration versus continuous therapy
- High-risk patient treatment optimization
Evaluates treatment efficacy through progression-free survival and response rates.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.